RVD with weekly subcutaneous bortezomib minimizes neuropathy and maintains efficacy in a diverse multiple myeloma cohort

被引：1
|
作者：
Gill, Amitoj [1 ]
Jayswal, Rani [2 ]
Weiss, Heidi [2 ]
Rhodes, Jill [1 ]
Hegazi, Mohamed [1 ]
Herzig, Geoffrey [1 ]
Herzig, Roger [2 ]
Krem, Maxwell [2 ]
机构：
[1] Univ Louisville, Louisville, KY 40292 USA
[2] Univ Kentucky, Markey Canc Ctr, Lexington, KY USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2019年 / 19卷 / 10期
关键词：
bortezomib; neuropathy; Tolerability;
D O I：
10.1016/j.clml.2019.09.349
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
SP-023
引用
收藏
页码：E210 / E210
页数：1
相关论文
共 50 条
  • [41] SUBCUTANEOUS BORTEZOMIB IN PATIENTS OVER 75 YEARS WITH MULTIPLE MYELOMA
    Violeta, Martinez-Robles
    Belen, Ballina
    Seila, Cerda
    Filomeno, Rondon
    Natalia, De Las Heras
    Jose-Antonio, Rodriguez-Garcia
    Fernando, Escalante
    HAEMATOLOGICA, 2016, 101 : 302 - 302
  • [42] Bortezomib-induced painful neuropathy in patients with multiple myeloma
    Bilinska, Malgorzata
    Usnarska-Zubkiewicz, Lidia
    Pokryszko-Dragan, Anna
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2013, 17 (05): : 421 - 426
  • [43] Neuropathy in multiple myeloma patients treated with bortezomib: A multicenter experience
    Caravita, Tommaso
    Petrucci, Maria Teresa
    Spagnoli, Alessandra
    Siniscalchi, Agostina
    Offidani, Massimo
    Federico, Vincenzo
    Falco, Patrizia
    Rizzo, Manuela
    Palumbo, Antonio
    de Fabritiis, Paolo
    BLOOD, 2007, 110 (11) : 280B - 280B
  • [44] Bortezomib-Induced Peripheral Neuropathy in Patients With Multiple Myeloma
    Berkowitz, Anne
    Walker, Suzanne
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2012, 16 (01) : 86 - 89
  • [45] Bortezomib neuropathy in patients treated for multiple myeloma: A multicenter experience
    Siniscalchi, A.
    Falco, P.
    Spagnoli, A.
    Palumbo, A.
    Rizzo, M.
    de Fabritiis, P.
    Amadori, S.
    Caravita, T.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 143 - 143
  • [46] Genetic Associations with Bortezomib Mediated Neuropathy in Multiple Myeloma.
    Corthals, Sophie L.
    Johnson, David C.
    de Knegt, Yvonne
    Goldschmidt, Hartmut
    Lokhorst, Henk
    Minvielle, Stephane
    Magrangeas, Florence
    Harousseau, Jean-Luc
    Durie, Brian G. M.
    Van Ness, Brian G.
    Morgan, Gareth J.
    Sonneveld, Pieter
    Loiseau, Herve Avet
    BLOOD, 2009, 114 (22) : 713 - 713
  • [47] BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY IN MULTIPLE MYELOMA PATIENTS
    Lalayanni, C.
    Iskas, M.
    Antoniou, A.
    Voutiadou, G.
    Georgiadou, E.
    Marvaki, A.
    Apostolou, C.
    Vadikoliou, C.
    Mallouri, D.
    Kaloyannidis, P.
    Anagnostopoulos, A.
    HAEMATOLOGICA, 2012, 97 : 615 - 616
  • [48] TREATABLE BORTEZOMIB-RELATED PERIPHERAL NEUROPATHY IN MULTIPLE MYELOMA
    Koeppen, S.
    Hense, J.
    Nolte, K. W.
    Weis, J.
    Schuler, M.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2011, 16 : S68 - S68
  • [49] Lenalidomide (Revlimid), Bortezomib (Velcade) and Dexamethasone (RVD) for Heavily Pretreated Relapsed or Refractory Multiple Myeloma
    Jimenez-Zepeda, Victor H.
    Reece, Donna E.
    Trudel, Suzanne
    Chen, Christine
    Kukreti, Vishal
    BLOOD, 2011, 118 (21) : 1266 - 1267
  • [50] Weekly bortezomib/methylprednisolone is effective and well tolerated in relapsed multiple myeloma
    Suvannasankha, Attaya
    Smith, Gina G.
    Juliar, Beth E.
    Abonour, Rafat
    CLINICAL LYMPHOMA & MYELOMA, 2006, 7 (02): : 131 - 134
12345